LYSOGENE
Gene therapy for disorders
- B2B
About LYSOGENE
A biopharmaceutical company specializing in gene therapy for children with neurodegenerative lysosomal storage disorders, founded by a mother determined to improve patients' lives
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Neuilly-sur-Seine, Île-de-France, France
- Founded
- 2009
- Revenue
- $4M – $31.5MTamtam estimate
- Website
- lysogene.com
- linkedin.com/company/lysogene
LYSOGENE at a glance
LYSOGENE is a B2B company in the Biotechnology Research industry, headquartered in Neuilly-sur-Seine, Île-de-France, France.
LYSOGENE was founded in 2009.
LYSOGENE has 11–50 employees.
LYSOGENE's revenue is $4M – $31.5M (Tamtam estimate).
Selling to companies like LYSOGENE?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies